Effects of phenolic compounds from lingonberry and crowberry on TRPA1 ion channel
Piippo, Iiro (2024)
Piippo, Iiro
2024
Bioteknologian ja biolääketieteen tekniikan kandidaattiohjelma - Bachelor's Programme in Biotechnology and Biomedical Engineering
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Hyväksymispäivämäärä
2024-09-17
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202408308450
https://urn.fi/URN:NBN:fi:tuni-202408308450
Tiivistelmä
Transient receptor potential ankyrin 1 (TRPA1) is a non-selective ion channel that has a role in nociception, chemosensation and thermosensation. TRPA1 channel mediates pain, cough, itch and neurogenic inflammation and has been shown to affect the regulation of multiple organ systems. It is mainly expressed in sensory neurons, but also found in other cell types such as epithelial cells and immune cells. TRPA1 channel is activated by a wide range of stimuli. These include noxious exogenous and endogenous chemical stimuli, cold and mechanical stimuli. TRPA1 antagonists are under development for the treatment of pain, cough, inflammation and other TRPA1-associated disorders.
Phenolic compounds are a structurally diverse group of compounds that share the phenolic structure where one or multiple hydroxyl groups attach to aromatic ring. These compounds occur naturally in plants, many of which are a part of the normal human diet. Phenolic compounds are secondary metabolites in plants and are associated with defence against plant pathogens and environmental stress such as ultraviolet radiation. Natural phenolic compounds have also been found to have antioxidant, antimicrobial and anti-inflammatory effects.
Berries are a rich source of phenolic compounds, and their composition is unique with high amounts of anthocyanins and other flavonoids, phenolic acids and polymeric tannins. This study focused on the phenolic compounds found in two arctic berries, namely lingonberry (Vaccinium vitis-idaea L.) and crowberry (Empetrum nigrum ssp. hermaphroditum), and their effects were investigated on the activity of the TRPA1 ion channel.
TRPA1 activity was investigated by measuring TRPA1-dependent changes in the intracellular calcium concentrations by fluo-3-acetoxymethyl ester (Fluo-3-AM) assay in A549 cells. The assay is based on the change in the fluorescence of the Fluo-3-AM molecule when it binds to calcium ion. A549 human lung epithelial cells were selected for the experiments based on earlier findings in the research group showing appropriate TRPA1 expression in these cells.
The effects of 13 phenolic compounds on the activity of the TRPA1 ion channel were measured under conditions where channel activation (agonism) and channel inhibition (antagonism) could be seen. As completely new findings, the flavonol myricetin was discovered to inhibit the activation of TRPA1 in a dose dependent manner and with a similar potency as the known TRPA1 antagonist A967079; in contrast, the phenolic acid 4-hydroxybenzoic acid increased the activity of the TRPA1 ion channel. In addition, resveratrol, p-coumaric acid and trans-ferulic acid were found to inhibit TRPA1 activity supporting previous literature. The results warrant confirmation with additional methods, particularly patch clamp and in vivo models.
The results may partially explain the previously observed health-promoting effects of lingonberry and crowberry. In addition, the findings may be exploited in the development of functional food products and novel medicines for the treatment of pain, inflammation and other TRPA1-related disorders.
Phenolic compounds are a structurally diverse group of compounds that share the phenolic structure where one or multiple hydroxyl groups attach to aromatic ring. These compounds occur naturally in plants, many of which are a part of the normal human diet. Phenolic compounds are secondary metabolites in plants and are associated with defence against plant pathogens and environmental stress such as ultraviolet radiation. Natural phenolic compounds have also been found to have antioxidant, antimicrobial and anti-inflammatory effects.
Berries are a rich source of phenolic compounds, and their composition is unique with high amounts of anthocyanins and other flavonoids, phenolic acids and polymeric tannins. This study focused on the phenolic compounds found in two arctic berries, namely lingonberry (Vaccinium vitis-idaea L.) and crowberry (Empetrum nigrum ssp. hermaphroditum), and their effects were investigated on the activity of the TRPA1 ion channel.
TRPA1 activity was investigated by measuring TRPA1-dependent changes in the intracellular calcium concentrations by fluo-3-acetoxymethyl ester (Fluo-3-AM) assay in A549 cells. The assay is based on the change in the fluorescence of the Fluo-3-AM molecule when it binds to calcium ion. A549 human lung epithelial cells were selected for the experiments based on earlier findings in the research group showing appropriate TRPA1 expression in these cells.
The effects of 13 phenolic compounds on the activity of the TRPA1 ion channel were measured under conditions where channel activation (agonism) and channel inhibition (antagonism) could be seen. As completely new findings, the flavonol myricetin was discovered to inhibit the activation of TRPA1 in a dose dependent manner and with a similar potency as the known TRPA1 antagonist A967079; in contrast, the phenolic acid 4-hydroxybenzoic acid increased the activity of the TRPA1 ion channel. In addition, resveratrol, p-coumaric acid and trans-ferulic acid were found to inhibit TRPA1 activity supporting previous literature. The results warrant confirmation with additional methods, particularly patch clamp and in vivo models.
The results may partially explain the previously observed health-promoting effects of lingonberry and crowberry. In addition, the findings may be exploited in the development of functional food products and novel medicines for the treatment of pain, inflammation and other TRPA1-related disorders.
Kokoelmat
- Kandidaatintutkielmat [10626]
